Hello, everyone, and welcome to another working week. It’s nice to see you again after our extended respite, which was exciting and fast-paced. Now, though, the usual routine has returned. But we all knew this would happen, yes? So as a shiny sun warms the Pharmalot campus this morning, we are brewing cups of stimulation, playing catch-up and assembling tidbits for your pleasure. Hope you have a smashing day and do stay in touch …
Hillary Clinton has taken more money in donations from employees of the 15 biggest US drug makers than all of the Republicans who attempted to run for president this year combined, according to Reuters, citing campaign finance disclosures. Clinton’s campaign took nearly $240,000 through the end of April, compared with nearly $168,000 for all of the Republicans together, including around $1,700 for Donald Trump, according to the filings.
The UK’s National Institute for Health and Care Excellence reiterated an earlier decision that Vertex Pharmaceuticals’s Orkambi cystic fibrosis treatment does not justify its “considerable cost,” PharmaTimes says. “We can only recommend treatments when we are certain they are both clinically effective and represent good value for money,” said professor Carole Longson, director of the NICE Center for Health Technology Evaluation.
About the Author Reprints
